Our company's periodic activity report for January-June 2023 has been published.

CranioCatch Bilişim Teknolojileri A.Ş. made significant strides in the first half of 2023, both in terms of product development and strategic collaborations. The startup successfully secured support from the KOSGEB R&D and Innovation Program, strengthening its R&D activities. Additionally, prominent dental professionals such as Dt. Mert Kandemir and Dt. Cennet İşbilir joined the user base, enhancing the company’s credibility within the dental community.

A major highlight of this period was CranioCatch's strategic partnership agreement with Dentaverse Global (UK) and Dentaverse MENA (Saudi Arabia), focusing on the integration of AI and Web3 technologies in dentistry. As part of this agreement, share swaps were executed, and an investment of $300,000 was committed to CranioCatch, with initial payments already transferred. The deal also grants Dentaverse MENA exclusive sales rights for the MENA region under the “Dentaverse AI powered by CranioCatch” brand, with revenue sharing set at 50%-50%.

CranioCatch also participated in prestigious industry events such as Teknofest 2023, IDEX Istanbul, and the International Dentistry Congress of Recep Tayyip Erdoğan University. Moreover, the company’s educational modules have been tested and adopted by institutions like the University of Mississippi and Lokman Hekim University, and commercial agreements were made with Çukurova University.

Financially, the company increased its capital through bonus issues and recorded total expenditures of approximately ₺1.26 million, primarily allocated to personnel, administrative expenses, and marketing. Several TÜBİTAK-supported R&D project applications were also submitted and are currently under review.

In summary, the period marks a dynamic phase for CranioCatch, combining technological progress, international collaborations, and market expansion efforts.